Filing Details

Accession Number:
0001415889-22-003267
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-22 17:37:55
Reporting Period:
2022-03-18
Accepted Time:
2022-03-22 17:37:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Ani Pharmaceuticals Inc ANIP Pharmaceutical Preparations (2834) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1871002 Chad Gassert C/O Ani Pharmaceuticals, Inc.
210 Main Street West
Baudette MN 56623
Svp - Corp. Dev. & Strategy No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-18 5,000 $27.15 388,226 No 4 P Indirect Held by Chali Properties LLC
Common Stock Acquisiton 2022-03-21 5,000 $27.87 393,226 No 4 P Indirect Held by Chali Properties LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by Chali Properties LLC
No 4 P Indirect Held by Chali Properties LLC
Footnotes
  1. The shares were acquired in multiple trades at prices ranging from $27.06 to $27.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. The Reporting Person holds voting and dispositive power over the shares held by Chali Properties LLC.
  3. The shares were acquired in multiple trades at prices ranging from $27.69 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.